Delving into the Latest Updates on Huili Pharmaceutical (Suzhou) Co., Ltd. with Synapse

Overview

Tags

Nervous System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Top 5 Drug Type	Count

Small molecule drug	1

主要目的：评价注射用RF16001在健康受试者中神经阻滞给药后的安全性。次要目的：评价注射用RF16001在健康受试者中神经阻滞给药后的药代动力学特征。探索性目的：评价注射用RF16001在健康受试者中神经阻滞给药后的药效学特征。

[Translation]

Primary objective: To evaluate the safety of RF16001 for injection following nerve block administration in healthy subjects. Secondary objective: To evaluate the pharmacokinetic profile of RF16001 for injection following nerve block administration in healthy subjects. Exploratory objective: To evaluate the pharmacodynamic profile of RF16001 for injection following nerve block administration in healthy subjects.

Start Date16 Oct 2025

Sponsor / Collaborator

Huili Pharmaceutical (Suzhou) Co., Ltd.

[+1]

CTR20233138

/ Not yet recruitingPhase 1

一项评估注射用HL008在中国精神分裂症患者中药代动力学、安全性和耐受性的开放、单次给药、剂量递增的探索性临床研究

[Translation] An open-label, single-dose, dose-escalation exploratory clinical study to evaluate the pharmacokinetics, safety and tolerability of HL008 for injection in Chinese patients with schizophrenia

主要研究目的：评价注射用HL008在中国精神分裂症患者单次给药的安全性和耐受性；次要研究目的：评价注射用HL008在中国精神分裂症患者中单次给药的药代动力学（PK）特征。

[Translation]

Primary study objective: To evaluate the safety and tolerability of a single dose of HL008 for injection in Chinese patients with schizophrenia; Secondary study objective: To evaluate the pharmacokinetic (PK) characteristics of a single dose of HL008 for injection in Chinese patients with schizophrenia.

Start Date-

Sponsor / Collaborator

Bosikon (Hangzhou) Biomedical Co., Ltd.

[+1]

100 Clinical Results associated with Huili Pharmaceutical (Suzhou) Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Huili Pharmaceutical (Suzhou) Co., Ltd.

Login to view more data

100 Deals associated with Huili Pharmaceutical (Suzhou) Co., Ltd.

Login to view more data

100 Translational Medicine associated with Huili Pharmaceutical (Suzhou) Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 May 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Approval

2

1

Phase 1

Login to view more data